11/24/2014 - 12:13 PM EST - Bioniche Life Sciences Inc. : announced the accomplishment of another major milestone in the execution of its strategic plan to become a focused late stage human therapeutics company with near term commercial potential. Effective immediately, the Company will begin operating under its new corporate name and identity, Telesta Therapeutics Inc. Bioniche Life Sciences Inc.
shares T.BNC are trading up $0.01 at $0.23.
